Gold Member Since 2016
Wuhan Hengwo Scien-Tech Co., Ltd.

Sunitinib  Malate, Chemical Raw Material, Steroid Hormone manufacturer / supplier in China, offering   CAS 341031-54-7 with Purity 99% Made by Manufacturer Sunitinib Malate, Oral Tren Prohormone Powders Trendione Trenavar, Female Hormone Estrogen Steroids Estradiol and so on.

(/ )

Supplier Homepage Product Pharmaceutical APIs   CAS 341031-54-7 with Purity 99% Made by Manufacturer Sunitinib Malate

  CAS 341031-54-7 with Purity 99% Made by Manufacturer Sunitinib Malate

Purchase Qty.:
(g)
10-99 100+
FOB Unit Price: US $1 US $0.78
Purchase Qty. (g) FOB Unit Price
10-99 US $1
100+ US $0.78
Get Latest Price
Production Capacity: 2 Tons/Year
Transport Package: 1 Kg/Foil Bag
Payment Terms: T/T, Western Union, Money Gram, Bitcoin

Request a custom order and have something just for you!

Send Customized Request
Basic Info
  • Model NO.: Sunitinib  Malate
  • Customized: Customized
  • Suitable for: Adult
  • Purity: >99%
  • Alias: Sunitinib Malate
  • Einecs No: C22h27fn4o2.C4h6o5
  • Molecular Weight: 532.566
  • Trademark: YC
  • Origin: Hubei, China
  • Powder: Yes
  • Certification: GMP, HSE, ISO 9001
  • State: Solid
  • Product Name: Sunitinib Malate
  • CAS Registry Number: 341031-54-7
  • Molecular Formula: C22h27fn4o2.C4h6o5
  • Appearance: White Powder
  • Specification: USD Standard
  • HS Code: 3001200010
Product Description
Sunitinib Malate CAS341031-54-7 with Purity 99% Made by Manufacturer
Product Name:    Sunitinib Malate
Synonyms:    SUNITINIB MALATE;N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate;N-[2-(Diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidine)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide(2S)-2-hydroxybutanedioatesalt;Sunitinib Malate(Sutent);Butanedioic acid, 2-hydroxy-, (2S)-, coMpd. with N-[2-(diethylaMino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)Methyl]-2,4-diMethyl-1H-pyrrole-3-carboxaMide (1:1);N-(2-(DiethylaMino)ethyl)-5-((Z)-(5-fluoro-1,2-dih;Butanedioic acid, 2-hydroxy-, (2S)-, coMpd. with N-[2-(diethylaMino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)Methyl]-2,4-diMethyl-1H-pyrrole-3-carboxaMide;(Z)-N-(2-(diethylaMino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)Methyl)-2,4-diMethyl-1H-pyrrole-3-carboxaMide (S)-2-hydroxysuccinate
CAS:    341031-54-7
MF:    C22H27FN4O2.C4H6O5
MW:    532.566
EINECS:    
Product Categories:    APIs;Heterocycles;Intermediates & Fine Chemicals;Pfizer compounds;Pharmaceuticals;Tyrosine Kinase Inhibitors;SU-11248;Inhibitors;Oxetanes
Mol File:    341031-54-7.mol
Sunitinib Malate Structure
Anticancer drug    Sunitinib malate is a kind of novel oral multi-targeted anticancer drugs and belongs to multi-targeted tyrosine kinase inhibitor with its trade name being "suntent". It was successfully developed by Pfizer Company and has dual anti-tumor effect. Moreover, it is the only therapeutic drug which can go beyond the 2-year survival period of advanced kidney cancer and plays a central role in the field of carcinoma and gastrointestinal stromal tumor therapeutic areas. It entered into market in February 2006 in the United States. This drug was the first anti-cancer drug which was approved by the US FDA and can simultaneously treat two diseases. 
Sunitinib exerts its therapeutic role through preventing the tumor cells from getting the blood and nutrients needed for growth. Clinical trials have showed that the drug can delay the growth rate of gastrointestinal stromal tumors, and can shrink the size of renal cell tumors. Sunitinib malate is the first novel targeted drug being capable of selectively targets drugs for a variety of new tyrosine kinase receptors. It combine two kinds of anti-tumor mechanisms including both stopping the formation of anti-angiogenic which is responsible for supplying blood to tumor and direct attack of tumor cells. It represents the advent of a new round of targeted therapies, being able to attack the tumor directly without the toxicity of the conventional chemotherapy. 
The indications of Sunitinib malate are as follows:
1, Patients who failed in the treatment with matinib mesylate or of intolerant gastrointestinal stromal tumors (GIST). 
2, inoperable advanced renal cell carcinoma (RCC).
3, advanced pancreatic endocrine tumors.
Uses    Anti-cancer drugs
Chemical Properties    Yellow Solid
Usage    Sunitinib Malate (Sutent, SU11248) is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit.
Usage    Sunitinib Malate is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit
Usage    A multi-kinase inhibitor targeting several receptor tyrosine kinases (RTK). Antineoplastic.

Company Profile

Wuhan Hengwo Scien-Tech Co., Ltd.,is a leading supplier of raw steroids in China.We specialize in producing and seliing various kinds of
Raw steroid powders,semi-finished liquid injectable/oral steroids,polypeptide and natural hormones,Cortiscosteroids,progestational
hormones,etc.With High quality raw materials and advanced clean workshop,as well as strict quality control,our steroid hormones got many good feedback from all over the world.


Technique support is available whenever you have questions in making the steroid powders into finished products or when using.With over 14 years'
experiences exporting steroids worldwide,we have a high customs pass rate,also packages will be free resent to you in case it get seized."Delivery
guarantee,Quality service"is our promisr for you!

Let's join hand,go further and win together!
Send your message to this supplier
Avatar
Mr. Gene
Sales Manager
*From:
To: Mr. Gene
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

Find Similar Products By Category